Awareness, Care & Treatment in Obesity Management (ACTION) Study
Completed
Conditions studied: Metabolism and Nutrition Disorder, Obesity
In brief
The ACTION (Awareness, Care, and Treatment In Obesity management) study aims to identify perceptions, attitudes, behaviours, and potential barriers to effective obesity care across three respondent types: 1) People with Obesity, 2) Healthcare Providers and 3) Employer Representatives in the US. Data is collected via online surveys using a cross-sectional, US-based stratified sample design.
Key facts
- Study ID
- NCT03223493
- Run by
- Novo Nordisk A/S
- People needed
- 3767
- Starts
- 2015-10-29
- Expected to finish
- 2015-11-12
- Last updated by the study team
- 2019-07-19
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- GENERAL POPULATION
- Agrees to AE reporting
- Age at least 18 years
- Lives in the US
- Current BMI at least 30 kg/sqm
- HEALTH CARE PROFESSIONALS
- Agrees to AE reporting
- Physician and board certified or NP/PA
- Facility located in the U.S. and not Vermont
- Spends at least 70% of time in direct patient care
- Seen at least 100 patients in past month
- Seen at least 10 patients in past month needing weight management
- In practice 2-35 years
- Not competitively employed
- Primary Care Providers
- Specialty is FP, IM, GP
- Less than 50% patients seen for obesity
- Obesity Specialists
- Obesity medicine or weight loss specialist or at least 50% of patients seen for obesity
- In practice 2-35 years
- EMPLOYERS
- Age at least 18 years
- Works in the US
- Director, Administrator, CHRO, VP or other title
- Responsible for making or influencing decisions about health insurance or health and wellness programs
You may not qualify if…
- None
Where it is running
- Novo Nordisk Investigational Site — Honeoye Falls, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.